GGrantIndex
Sort

82,697 grants matching vaccine development

The UCSD CD4 Collaborative Clinical Trial Unit

$4,550,799
Constance Ann Benson · University Of California, San Diego · UM1 · FY2019 · AI

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$4,548,182
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR

EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)

$4,547,160
Marianne Ward · Duke University · N01 · FY2019 · AI

Center for Translational Research in Health Disparities

$4,544,313
Kevin Sean Kimbro · Morehouse School Of Medicine · U54 · FY2023 · MD

Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS

$4,544,275
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA

Duke Center for HIV Structural Biology

$4,534,742
Priyamvada Acharya · Duke University · U54 · FY2025 · AI

Studies of Inherited Causes of Fungal Susceptability

$4,532,963
Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages

$4,527,376
Barton F Haynes · Duke University · U19 · FY2020 · AI

UCLA AIDS Prevention and Treatment Clinical Trials Unit

$4,522,429
Judith S. Currier · University Of California Los Angeles · UM1 · FY2019 · AI

Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants

$4,521,374
Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI

Task X18: Evaluation of Filovirus Vaccines

$4,518,280
Randi Hornback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2016 · AI

Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever

$4,515,928
Matthias Schnell · Thomas Jefferson University · N01 · FY2020 · AI

Boston HIV CTU

$4,506,411
Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2025 · AI

Development of Technologies that Accelerate the Immune Response to Vaccines

$4,505,171
Osmer Marjorie · Geneva Foundation · N01 · FY2018 · AI

HIV VACCINE DESIGN AND DEVELOPMENT TEAMS - PART B

$4,504,514
Charles A Nicolette · · N01 · FY2007 · AI

Clinical Trials of Biodefense Vaccines (Dengue)

$4,502,292
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Pathogenesis And Treatment Of Aplastic Anemia

$4,499,584
Neal S Young · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL

Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans

$4,499,507
Anna Karolina Palucka · Baylor Research Institute · U19 · FY2010 · AI

Center for Translational Research in Health Disparities

$4,498,932
Kevin Sean Kimbro · Morehouse School Of Medicine · U54 · FY2024 · MD

Synthetic DNA-launched and adjuvanted Env immunogens for HIV

$4,497,948
David B. Weiner · Wistar Institute · U19 · FY2023 · AI

Advancement of Treatments for Ebola and Marburg Virus Infections

$4,496,579
Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2018 · AI

Enhancing anti-tumor immunity in head and neck neoplasms

$4,490,667
Clint Allen · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Epitopes recognized by Influenza and Flavivirus responsive CD4+ T cells

$4,489,824
Benaroya Research Inst At Virginia Mason · N01 · FY2009 · AI

Core 3: Non-human Primate Core

$4,487,359
Barton F Haynes · Duke University · P01 · FY2021 · AI

Arming the Immune System Against Pathogens

$4,457,456
Laurie H Glimcher · Harvard School Of Public Health · P01 · FY2007 · AI